As gene therapies advance toward indications with larger patient populations, adeno-associated virus (AAV) manufacturers are under growing pressure to deliver high-quality vectors at substantially ...
Adeno-associated viruses (AAVs) are used in nearly a dozen FDA-approved therapies and more than 900 R&D projects to deliver therapeutic payloads to cells. Yet, large-scale AAV production is still a ...
High-throughput virology, design of experiments, and small-molecule production enhancers optimize yield and increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results